appno,pubdate,pubnum,title,abstract,invs,assignee,xref,filedate,govint,parentcase,childcase,date371,pctpubno
13799632,20140410,20140096814,METHOD OF INCREASING THE BAND GAP OF IRON PYRITE BY ALLOYING WITH OXYGEN,"A method of increasing the band gap of iron pyrite by alloying with oxygen is disclosed. According to one embodiment, a method comprises alloying iron pyrite (FeS) with oxygen to form an iron pyrite and oxygen alloy (FeSO). The iron pyrite and oxygen alloy (FeSO) has a band gap greater than iron pyrite (FeS).",[Ruqian Wu][Matt Law][Jun Hu][Yanning Zhang],"","The present application claims the benefit of and priority to U.S. Provisional Application No. 61/677,994 titled &#x201C;METHOD OF INCREASING THE BAND GAP OF IRON PYRITE BY ALLOYING WITH OXYGEN,&#x201D; filed on Jul. 31, 2012, which is hereby incorporated by reference in its entirety.",20130313,"This invention was made with Government support under Grant No. CHE-1035218, awarded by the National Science Foundation. The Government has certain rights in this invention.","","","",""
14045011,20140410,20140097277,"BIODEGRADABLE IRON-CONTAINING COMPOSITIONS, METHODS OF PREPARING AND APPLICATIONS THEREFOR","The invention relates to biodegradable iron alloy-containing compositions for use in preparing medical devices. In addition, biodegradable crystalline and amorphous compositions of the invention exhibit properties that make them suitable for use as medical devices for implantation into a body of a patient. The compositions include elemental iron and one or more elements selected from manganese, magnesium, zirconium, zinc and calcium. The compositions can be prepared using a high energy milling technique. The resulting compositions and the devices formed therefrom are useful in various surgical procedures, such as but not limited to orthopedic, craniofacial and cardiovascular.",[PRASHANT N. KUMTA][SUNG JAE CHUNG][PARTHA SAHA][OLEG VELIKOKHATNYI][MONI KANCHAN DATTA][DAE HO HONG][DA-TREN CHOU],[UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION],"This application claims priority under 35 U.S.C. &#xA7;119(e) to U.S. Provisional Patent Application Ser. No. 61/710,338, filed Oct. 5, 2012, entitled &#x201C;Biodegradable Iron-Containing Compositions, Methods of Preparing and Applications Therefor&#x201D;.",20131003,The invention was made with government support under EEC-0812348 awarded by the National Science Foundation. The government has certain rights in the invention.,"","","",""
14046947,20140410,20140097537,THIN FILM COMPOSITIONS AND METHODS,"Certain embodiments of the present invention include a versatile and scalable process, “patterned regrowth,” that allows for the spatially controlled synthesis of lateral junctions between electrically conductive graphene and insulating h-BN, as well as between intrinsic and substitutionally doped graphene. The resulting films form mechanically continuous sheets across these heterojunctions. These embodiments represent an element of developing atomically thin integrated circuitry and enable the fabrication of electrically isolated active and passive elements embedded in continuous, one atom thick sheets, which may be manipulated and stacked to form complex devices at the ultimate thickness limit.",[Jiwoong Park][Mark Levendorf][Cheol-Joo Kim][Lola Brown],"","This application claims the benefit of U.S. Provisional Application No. 61/710,487 filed Oct. 5, 2012, which is incorporated by reference in its entirety.",20131005,"This invention was made with government support under FA9550-09-1-0691 and FA9550-10-1-0410, awarded by Air Force Office of Scientific Research, and under DMR-1120296, DGE-0707428, and ECS-0335765, awarded by the National Science Foundation. The United States government has certain rights in the invention.","","","",""
13885384,20140410,20140097829,SEARCH COIL,"A device includes an excitation coil, a detector coil, and a processing circuit. The excitation coil is aligned about a volume. The excitation coil is configured to carry a first and second biasing current and generate a magnetic field in the volume. The detector coil is configured to generate an electrical signal based on a detected field within the volume. The detected field is based on the magnetic field. The processing circuit is configured to generate data based on the electrical signal.",[Jian-Ping Wang][Liang Tu],[Regents of the University of Minnesota],"This patent application claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 61/413,884, entitled &#x201C;MAGNETIC NANOPARTICLE-BASED MAGNETIC COLORING,&#x201D; filed on Nov. 15, 2010 (Attorney Docket No. 600.831PRV), which is hereby incorporated by reference herein in its entirety.This patent application is also related to Wang et. al, PCT application Ser. No. ______, entitled &#x201C;GMR SENSOR,&#x201D; filed on Nov. 15, 2011 (Attorney Docket No. 600.831WO1).",20111115,This invention was made with government support under award number 1717-522-6686 from National Science Foundation. The government has certain rights in this invention.,"","",20131223,PCT/US11/60837
13984228,20140410,20140099506,Biodegradable Polymers with Sulfenamide Bonds for Drug Delivery Applications,The present invention provides polysulfenamides and methods of making same.,[Ned B. Bowden][Denison J. Kuruvilla][Aliasger K. Salem][Jun Yoo],[University of Iowa Research Foundation],"",20120210,"This invention was made with government support under contract CHE-0848162 awarded by the National Science Foundation, and under contracts 1R21CA13345-01/1R21CA128414-01A2 awarded by the National Institutes of Health. The government has certain rights in the invention.","","",20131218,PCT/US12/24734
14056603,20140410,20140099646,METHOD AND SYSTEM FOR SAMPLE PREPARATION,"A method for preparing a sample by utilizing a shearing force in the presence of a size stabilizer to break apart the sample to obtain nucleic acid molecules in a usable size range. Once nucleic acid molecules are obtained, magnetic nanoparticles are used to concentrate and clean the nucleic acid molecules for further testing.",[Dennis M. Connolly][Tara Holz][Vera Tannous][Christopher Kilcoin][Konstantin Aptekarev][David B. Bailey][Richard S. Murante][Nate Wescott],"[Integrated Nano-Technologies, LLC]","This application claims priority from U.S. Provisional Patent Application Ser. No. 61/715,003 (filed Oct. 17, 2012). This application is a continuation-in-part of U.S. patent application Ser. No. 12/785,864, filed May 23, 2010 which claims priority from U.S. Provisional Patent Application Ser. No. 61/180,494, filed May 22, 2009, and is also a continuation-in-part of U.S. patent application Ser. No. 12/754,205, filed Apr. 5, 2010 which claims priority from U.S. Provisional Patent Application Ser. No. 61/166,519, filed Apr. 3, 2009. The contents of the aforementioned applications are hereby incorporated by reference in their entirety.",20131017,"The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of one or more of the following Grant Award Nos. DMI-0450472 and IIP-0450472 awarded by National Science Foundation, Contract No. W81XWH-07-2-0109 awarded by US Army Medical Research and Material Command, Contract Nos. W911NF-06-1-0238 and W911NF-09-C-0001 awarded by US Army RDECOM ACQ CTR.",12785864,14056603,"",""
13885359,20140410,20140099663,GMR SENSOR,"A system includes a first sensor, a field source, and a processor. The first sensor includes a surface and has an electrical resistance determined by a magnetic field at the surface. The field source is configured to provide a biasing magnetic field to the surface. The biasing magnetic field is aligned parallel to the surface and aligned perpendicular relative to the surface. The magnetic field has a frequency. The processor is coupled to the sensor and is configured to determine a parameter based on a measure of a change in the resistance. The change in the resistance corresponds to the resistance at a time before onset of a magnetic field perturbance at the surface and a time after the onset of the magnetic field perturbance at the surface.",[Jian-Ping Wang][Yuanpeng Li],[Regents of the University of Minnesota],"This patent application claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 61/413,884, entitled &#x201C;MAGNETIC NANOPARTICLE-BASED MAGNETIC COLORING,&#x201D; filed on Nov. 15, 2010 (Attorney Docket No. 600.831PRV), which is hereby incorporated by reference herein in its entirety.This patent application is also related to Wang et. al, PCT Application Serial Number ______, entitled &#x201C;SEARCH COIL,&#x201D; filed on Nov. 15, 2011 (Attorney Docket No. 600.831WO2).",20111115,This invention was made with government support under award number 1717-522-6686 from National Science Foundation. The government has certain rights in this invention.,"","",20131223,PCT/US2011/060828
14050702,20140410,20140100131,Methods and Reagents for Target Isolation from a Sample,"The present invention provides methods and kits for isolating a target of interest from a sample, where the methods involve use of nucleic acid strand displacement technology.",[Xiaohu GAO][Christine PROBST][Pavel S. ZRAZHEVSKIY],"","This application claims priority to U.S. Provisional Patent Application Ser. No. 61/712,102, filed Oct. 10, 2012, incorporated by reference herein in its entirety.",20131010,"This invention was made with government support under grant no. R01 CA131797 awarded by the National Institutes of Health, grant no. 0645080 awarded by the National Science Foundation, and graduate research fellowship no. DGE-0718124 awarded by the National Science Foundation. The government has certain rights in the invention.","","","",""
13998148,20140410,20140100173,Nitrile-containing enzyme inhibitors and ruthenium complexes thereof,"The invention provides nitrile-containing protease inhibitors caged to ruthenium compounds. The nitrile-caged ruthenium compounds provide inactivated inhibitors that can be delivered to surface or site for activation, for example, but exposure to light. The invention also provides methods for delivering protease inhibitors to subjects for the therapeutic treatment of conditions such as cancer.",[Jeremy J. Kodanko][Claudia Turro],[The Ohio State University Research Foundation][Wayne State University],"This application claims priority under 35 U.S.C. &#xA7;119(e) to U.S. Provisional Patent Application No. 61/710,552, filed Oct. 5, 2012, which is incorporated herein by reference.",20131007,This invention was made with government support under CHE-0911354 and CHE-1213646 awarded by the National Science Foundation and GM 833552 and EB016072 awarded by the National Institutes of Health. The government has certain rights in the invention.,"","","",""
14028999,20140410,20140100242,INHIBITION OF QUORUM SENSING-MEDIATED PROCESSES IN BACTERIA,"Methods are provided for identifying molecules that can be used to positively and negatively manipulate quorum-sensing-mediated communication to control bacterial behavior. Small-molecule antagonists that disrupt quorum-sensing-mediated activities are identified. Methods are provided for disrupting detection of acyl-homoserine lactone autoinducer in Gram-negative bacteria by contacting the bacteria with the antagonists. Methods of inhibiting quorum sensing-mediated activity in Gram-negative bacteria are provided wherein the activity is pathogenicity, bioluminescence, siderophore production, type III secretion, or metalloprotease production.",[Bonnie Bassler][Lee Swem],[THE TRUSTEES OF PRINCETON UNIVERSITY],"This application is a continuation of U.S. patent application Ser. No. 12/995,476, filed Jan. 13, 2011, which is a National Stage of PCT Application No. PCT/US09/03348, which claims priority to U.S. Provisional Application No. 61/130,685, filed Jun. 2, 2008 and U.S. Provisional Application No. 61/188,310, filed Aug. 7, 2008, all of which are herein incorporated in their entirety.",20130917,"This invention was made with government support under Grant No. GM065859; Grant No. GM787552 and Grant No. AI054442 awarded by the National Institutes of Health and under Grant No. MCB0343821 and Grant No. MCB0639855 awarded by the National Science Foundation. The government has certain rights in the invention.The antagonist screen was partly funded with federal funds supplied to the National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health, under Contract No. N01-CO-12400 and has been performed with the assistance of the Chemical Biology Platform of the Broad Institute of Harvard and MIT. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Service, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government.",12995476,14028999,"",""
13912499,20140410,20140100289,METHODS AND COMPOSITIONS FOR TREATING MAMMALIAN NERVE TISSUE INJURIES,"To achieve, an in vivo repair of injured mammalian nerve tissue, an effective amount of a biomembrane fusion agent is administered to the injured nerve tissue. The application of the biomembrane fusion agent may be performed by directly contacting the agent with the nerve tissue at the site of the injury. Alternatively, the biomembrane fusion agent is delivered to the site of the injury through the blood supply after administration of the biomembrane fusion agent to the patient. The administration is preferably by parenteral administration including including intravascular, intramuscular, subcutaneous, or intraperitoneal injection of an effective quantity of the biomembrane fusion agent so that an effective amount is delivered to the site of the nerve tissue injury.",[RIYI SHI][RICHARD B. BORGENS],"","This application claims the benefit of U.S. Provisional Patent Application No. 60/286,200 filed Apr. 24, 2001, which is hereby incorporated by reference in its entirety.",20130607,This invention was made in part with government support under grant number DAMD1 7-94-J-4242 awarded by the Department of the Army and grant number BES9631560 awarded by the National Science Foundation. Further financial support for development of this invention was provided by NSF grant CCR 92-22467 and NIH grant RO1 NS39288-01. The Government has certain rights in the invention.,12508184,13912499,"",""
13644369,20140410,20140100354,PEPTOID COMPOSITIONS AND METHODS OF USING THE SAME,"Novel peptoids are disclosed that have a formula represented by the following formulae Ia and Ib: wherein X, Y, R, and n are as described herein. The peptoids demonstrate catalytic activity and are useful in substrate-selective catalytic transformations, including asymmetric catalytic transformations.",[Kent KIRSHENBAUM][Galia Maayan][Michael Ward],[],"The present application claims the benefit under 35 U.S.C. &#xA7;119 of U.S. Provisional Application Ser. No. 61/053,958 filed May 16, 2008. The contents of said provisional application is hereby incorporated by reference in its entirety.",20121004,"This invention was made with government support under Grant No. 0645361 awarded by the NSF. Accordingly, the United States Government has certain rights in the invention.","","","",""
14103430,20140410,20140101746,SYSTEMS AND METHODS FOR INHIBITING ATTACKS WITH A NETWORK,"Systems and methods for inhibiting attacks with a network are provided. In some embodiments, methods for inhibiting attacks by forwarding packets through a plurality of intermediate nodes when being transmitted from a source node to a destination node are provided, the methods comprising: receiving a packet at one of the plurality of intermediate nodes; determining at the selected intermediate node whether the packet has been sent to the correct one of the plurality of intermediate nodes based on a pseudo random function; and forwarding the packet to the destination node, based on the determining. In some embodiments an intermediate node is selected based on a pseudo random function. In some embodiments, systems and methods for establishing access to a multi-path network are provided.",[Angelos Stavrou][Angelos D. Keromytis],[The Trustees of Columbia University in the City of New York],"This application is a divisional of U.S. patent application Ser. No. 12/048,533, filed Mar. 14, 2008, which is a national stage application under 35 U.S.C. &#xA7;371 of International Patent Application No. PCT/US2006/036327, filed Sep. 18, 2006, which claims the benefit of U.S. Patent Application No. 60/717,716, filed Sep. 16, 2005, each of which is hereby incorporated by reference herein in its entirety.",20131211,This invention was made with government support under Award No. 0426623 awarded by the National Science Foundation. The government has certain rights in the invention.,12048533,14103430,"",""
